1. Baker, R.J., Kozoll, D.D. and Meyer, K.A. 1957. The use of surface area as a basis for establishing the normal blood volume.Surg. Gynecol. Obst.,104, 183–189.
2. Book, S.A. 1982. Scaling toxicity from laboratory animals to people: an example with nitrogen dioxide.J. Toxicol. Environ. Health,9, 710–725.
3. Boxenbaum, H. and D'Souza, R.W. 1990. Interspecies pharmacokinelic scaling, biological design and neoteny. In: Testa, B. (ed.),Advances in Drug Research, Vol.19. pp. 139–196. Academic Press, London.
4. Boxenbaum, H. and Fertig, J.B. 1984. Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species.European J. Drug Metabol. Pharmacokin.,9, 177–183.
5. Brody, S. and Procter, R.C. 1932. Further investigations of surface area in energy metabolism.Mo. Res. Bull.,116.